Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows From Operating Activities:
Net loss	$ (4,181,335)	$ (4,271,309)
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on extinguishment of note payable	(17,893)	(41,920)
Non-cash interest expense - warrants	72,473	28,695
Warrant modification expense	1,100
Stock-based compensation:
Stock-based compensation	309,297	404,978
Changes in operating assets and liabilities:
Prepaid expenses	241,125	243,300
Other current assets	11,675	19,605
Accounts payable	569,076	900,538
Accrued compensation	126,920	25,147
Net Cash Used In Operating Activities	(1,935,836)	(1,625,601)
Cash Flows From Financing Activities:
Proceeds from issuance of common stock and warrants	415,625
Proceeds from issuance of Series B Convertible Preferred Stock and warrants	776,001
Repayment of financing liability	(48,548)	(191,460)
Net Cash Provided By Financing Activities	1,936,625	1,405,518
Net Increase (Decrease) In Cash	789	(220,083)
Cash - Beginning of Period	22,203	222,665
Cash - End of Period	22,992	2,582
Supplemental Disclosures of Cash Flow Information:
Interest
Income taxes		949
Non-cash investing and financing activities:
Common stock issued in satisfaction of accrued compensation	(45,000)
Common stock issued in connection with payment of Series A, B, and C Convertible Preferred Stock dividends in-kind	677,982	602,102
Financing of Director and Officer insurance	321,500	321,500
Conversion of Series C Convertible Preferred Stock into common stock		400
Conversion of accrued expenses into note principal		413,018
Accrual of warrant obligations in connection with issuance of notes payable		40,167
Warrants issued in satisfaction of accrued warrant obligation		(40,167)
Issuance of warrants in connection with the issuance of notes payable	200,404	141,672
Issuance of warrants in connection with the exchange of notes payable	12,107
Accrual of earned preferred stock dividends	(1,017,520)	(907,516)
Conversion of convertible notes payable and accrued interest into Series C Preferred Stock and common stock	104,910	546,194
Issuance of warrants in connection with issuance of Series B Preferred Stock	103,900
Issuance of embedded derivative liabilities in connection with issuance of Series B Preferred Stock	62,600
Issuance of embedded derivative liabilities in connection with issuance of Series C Preferred Stock	1,700
Extinguishment of note payable for common stock		58,080
Common Stock [Member]
Stock-based compensation:
Stock-based compensation	272,493	341,269
Warrant [Member]
Stock-based compensation:
Stock-based compensation	36,804	63,709
Nonrelated Party [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Interest expense - amortization of debt discount	112,218	107,487
Change in fair value of derivative liabilities	50,034
Changes in operating assets and liabilities:
Accrued expenses	(72,095)	53,697
Accrued interest	108,716	165,030
Cash Flows From Financing Activities:
Proceeds from issuance of convertible notes payable		919,960
Proceeds from issuance of notes payable	250,000
Proceeds from advances payable	59,375
Repayment of notes payable	(6,250)
Related Party [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Interest expense - amortization of debt discount	111,434	254,205
Change in fair value of derivative liabilities	31,570
Changes in operating assets and liabilities:
Accrued expenses	43,500	43,500
Accrued interest	546,349	441,446
Cash Flows From Financing Activities:
Proceeds from issuance of convertible notes payable	146,672	677,018
Proceeds from issuance of notes payable	250,000
Proceeds from advances payable	100,000
Repayment of notes payable	$ (6,250)